Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+)

NCT04351919 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped \- Interest in the use of HCQ is controversial.

Conditions

Patients With COVID19

Interventions

DRUG: Hydroxychloroquine
DRUG: Azithromycin

Sponsor

Abderrahmane Mami Hospital

Collaborators

[object Object]
[object Object]